1. Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1 Rev.
- Author
-
Reddy TR, Xu W, Mau JK, Goodwin CD, Suhasini M, Tang H, Frimpong K, Rose DW, and Wong-Staal F
- Subjects
- Adaptor Proteins, Signal Transducing, Antibodies metabolism, Carrier Proteins antagonists & inhibitors, Carrier Proteins metabolism, Cells, Cultured virology, Chloramphenicol O-Acetyltransferase genetics, Cytoplasm metabolism, DNA-Binding Proteins, Enzyme Inhibitors pharmacology, Fatty Acids, Unsaturated pharmacology, Gene Expression Regulation, Viral, Genes, Dominant, Genes, Reporter, HeLa Cells virology, Humans, Kinetin, Mutation, Purines pharmacology, RNA-Binding Proteins antagonists & inhibitors, Response Elements, rev Gene Products, Human Immunodeficiency Virus, Exportin 1 Protein, Gene Products, rev, HIV-1 physiology, Karyopherins, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Receptors, Cytoplasmic and Nuclear, Virus Replication genetics
- Abstract
The HIV-1 Rev protein facilitates the nuclear export of mRNA containing the Rev response element (RRE) through binding to the export receptor CRM-1. Here we show that a cellular nuclear protein, Sam68 (Src-associated protein in mitosis), specifically interacts with RRE and can partially substitute for as well as synergize with Rev in RRE-mediated gene expression and virus replication. Differential sensitivity to leptomycin B, an inhibitor of CRM-1, indicates that the export pathways mediated by Rev and Sam68 are distinct. C-terminally deleted mutants of Sam68 inhibited the transactivation of RRE-mediated expression by both wild-type Sam68 and Rev. They were retained in the cytoplasm and impeded the nuclear localization of Rev in co-expressed cells. These mutants also inhibited wild-type HIV-1 replication to the same extent as the RevM10 mutant, and may be useful as anti-viral agents in the treatment of AIDS.
- Published
- 1999
- Full Text
- View/download PDF